Complete and lasting healing of bone melanoma metastasis after hyperthermic limb perfusion.
Jacopo
J
Pigozzo
Costanza
C
De Rossi
Carlo Riccardo
CR
Rossi
Donato
D
Nitti
Vanna Chiarion
VC
Sileni
D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000627:therapeutic use; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000556:secondary*; D010478:Chemotherapy, Cancer, Regional Perfusion; D004164:Diphosphonates / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D008297:Male; D008545:Melanoma / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000556:secondary*; D008558:Melphalan / Q000008:administration & dosage / Q000627:therapeutic use; D049268:Positron-Emission Tomography; D012878:Skin Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology*; D013977:Tibia / Q000000981:diagnostic imaging; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage / Q000627:therapeutic use; D055815:Young Adult; D000077211:Zoledronic Acid
D018906:Antineoplastic Agents, Alkylating; D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; C439524:TNF protein, human; D014409:Tumor Necrosis Factor-alpha; D000077211:Zoledronic Acid; D008558:Melphalan